Hunan Huateng Pharmaceutical Co., Ltd. (hereafter called Huateng Pharma), founded in August 2013, is a high-tech enterprise dedicated to the research and development and production of high-end biomedical chemical products, as well as the development of precision-targeted anti-tumor drugs. The company develops and produces thousands of products, including monodisperse and polydisperse PEG derivatives, high-end biochemical reagents, pharmaceutical intermediates, APIs, preparations and targeted anti-tumor drugs.
Huateng Pharma is committed to the development, manufacturing, marketing, and distribution of high-end biomedical products to clients worldwide. In 2020, a comprehensive production base built with an investment of 350 million yuan in Wangcheng Tongguan Park has been completed and put into production. The production base has fully realized intelligent and large-scale production, equipped with modern multi-functional production workshops and storage centers, 100,000-class dust-fre
pharma intermediates, peg linkers, chemicals